Genome Editing Market 規模およびシェア分析 - 成長トレンドおよび予測 (2024 - 2031)

Genome Editing Market is segmented By Type of Gene Editing Technique (CRISPR-Cas System, TALENs, Meganucleases, ZFNs, Other Techniques), By Type of Therapy (Cell Therapies, Gene Therapies, Other Therapies), By Gene Editing Approach (Gene Knock-Out Approaches, Gene Knock-In Approaches), By Gene Delivery Method(Ex-Vivo Delivery Methods, In-Vivo Delivery Methods), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of Genome Editing Market

Genome Editing Marketで動作する主要なプレーヤーは、CRISPRの治療薬、Editasの薬、Intelliaの治療薬、ビーム治療薬、カリブバイオサイエンス、Arcturus治療薬、センチュリーセラピューティクス、グラファイトバイオ、プライム医薬品、およびVorバイオ医薬品が含まれます。

Genome Editing Market Leaders

  • クリスタル 治療薬
  • 編集薬
  • インテルリア治療薬
  • ビーム治療薬
  • カリブバイオサイエンス
*Disclaimer: Major players are listed in no particular order.

Genome Editing Market - Competitive Rivalry, 2023

Market Concentration Graph

Genome Editing Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights